Ch. Clemm

1.8k total citations · 1 hit paper
26 papers, 1.3k citations indexed

About

Ch. Clemm is a scholar working on Surgery, Hematology and Oncology. According to data from OpenAlex, Ch. Clemm has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Hematology and 6 papers in Oncology. Recurrent topics in Ch. Clemm's work include Testicular diseases and treatments (10 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). Ch. Clemm is often cited by papers focused on Testicular diseases and treatments (10 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). Ch. Clemm collaborates with scholars based in Germany. Ch. Clemm's co-authors include W. Wilmanns, Georg Ledderose, G. Brehm, J. Mittermüller, M. U. Heim, Ernst Holler, U. Jehn, A. Gerl, HJ Kolb and Jörg T. Hartmann and has published in prestigious journals such as Blood, International Journal of Cancer and European Journal of Cancer.

In The Last Decade

Ch. Clemm

22 papers receiving 1.3k citations

Hit Papers

Donor leukocyte transfusions for treatment of recurrent c... 1990 2026 2002 2014 1990 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
    1990 1.1k citations J. Mittermüller, Ch. Clemm et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ch. Clemm Germany 8 941 624 450 210 160 26 1.3k
J. C. W. Marsh United Kingdom 16 984 1.0× 374 0.6× 349 0.8× 319 1.5× 144 0.9× 26 1.3k
Steve Kornblau United States 10 1.2k 1.2× 404 0.6× 369 0.8× 253 1.2× 69 0.4× 16 1.4k
Marion M. Roberts Australia 10 659 0.7× 235 0.4× 313 0.7× 185 0.9× 74 0.5× 16 856
Monic J. Stuart United States 15 953 1.0× 443 0.7× 431 1.0× 456 2.2× 47 0.3× 26 1.5k
C Anasetti United States 12 1.0k 1.1× 676 1.1× 219 0.5× 127 0.6× 70 0.4× 18 1.2k
Jérôme Rey France 22 596 0.6× 605 1.0× 347 0.8× 527 2.5× 39 0.2× 76 1.4k
Maria Rosa Motta Italy 18 762 0.8× 480 0.8× 469 1.0× 176 0.8× 54 0.3× 46 1.2k
Édouard Forcade France 18 674 0.7× 372 0.6× 441 1.0× 195 0.9× 46 0.3× 105 1.2k
P Coser Italy 15 490 0.5× 154 0.2× 339 0.8× 215 1.0× 57 0.4× 38 914
Stern Ac Netherlands 10 590 0.6× 210 0.3× 438 1.0× 106 0.5× 113 0.7× 11 858

Countries citing papers authored by Ch. Clemm

Since Specialization
Citations

This map shows the geographic impact of Ch. Clemm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ch. Clemm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ch. Clemm more than expected).

Fields of papers citing papers by Ch. Clemm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ch. Clemm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ch. Clemm. The network helps show where Ch. Clemm may publish in the future.

Co-authorship network of co-authors of Ch. Clemm

This figure shows the co-authorship network connecting the top 25 collaborators of Ch. Clemm. A scholar is included among the top collaborators of Ch. Clemm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ch. Clemm. Ch. Clemm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clemm, Ch., et al.. (2008). Behandlung nicht-seminomatöser Hodentumoren im Stadium I-II B*. DMW - Deutsche Medizinische Wochenschrift. 114(34). 1276–1282.
2.
Clemm, Ch., Wolfgang E. Berdel, R. Hartenstein, et al.. (2008). Münchner Nachsorge-Schema bei fortgeschrittenen nicht-seminomatösen Hodentumoren: Nutzen und Kosten. DMW - Deutsche Medizinische Wochenschrift. 111(31/32). 1181–1185. 1 indexed citations
3.
Jehn, U., Ch. Clemm, & Georg Ledderose. (2008). Hautnekrosen und Ergotismus nach prophylaktischer Gabe von Heparin-Dihydroergotamin. DMW - Deutsche Medizinische Wochenschrift. 108(30). 1148–1150.
4.
Bokemeyer, Carsten, Aude Fléchon, Sally Stenning, et al.. (2002). Prognostic factors in patients (pts) with advanced metastatic seminoma (SEM) treated with either single agent carboplatin (CP) or cisplatin-based (DDP) combination chemotherapy (CTX): a meta-analysis of prospective European trials.. UCL Discovery (University College London). 2 indexed citations
5.
Bokemeyer, Carsten, Christian Kollmannsberger, A. Harstrick, et al.. (1999). Treatment of patients with cisplatin‐refractory testicular germ‐cell cancer. International Journal of Cancer. 83(6). 848–851. 29 indexed citations
6.
Gerl, A., R. Lamerz, K. Mann, Ch. Clemm, & W. Wilmanns. (1997). Is serum tumor marker half-life a guide to prognosis in metastatic nonseminomatous germ cell tumors?. PubMed. 17(4B). 3047–9. 6 indexed citations
7.
Clemm, Ch., et al.. (1995). 909 Chemotherapy in far advanced seminoma. European Journal of Cancer. 31. S189–S189. 3 indexed citations
8.
Gerl, A., Ch. Clemm, Peter Köhl, Andreas Schalhorn, & W. Wilmanns. (1994). ADJUVANT CHEMOTHERAPY OF STAGE-II NONSEMINOMATOUS TESTICULAR CANCER. Oncology Reports. 1(1). 209–12. 2 indexed citations
9.
Kolb, HJ, Ernst Holler, J. Mittermüller, et al.. (1992). Adoptive Immunotherapy in Human and Canine Chimeras. Hämatologie und Bluttransfusion. 12 Suppl 3. 595–600. 7 indexed citations
10.
Mittermüller, J., Ch. Clemm, Ernst Holler, et al.. (1990). Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 76(12). 2462–2465. 1134 indexed citations breakdown →
11.
Clemm, Ch.. (1989). [Long-term side effects of successful anti-tumor therapy. 2: Effects on fertility and bone marrow function; risk of secondary neoplasms].. PubMed. 107(30). 636–40. 1 indexed citations
12.
Kolb, HJ, U. Walther, J. Mittermüller, et al.. (1989). Myeloablative conditioning for marrow transplantation in myelodysplastic syndromes and paroxysmal nocturnal haemoglobinuria.. PubMed. 4(1). 29–34. 23 indexed citations
13.
Heim, M. U., Michael Schleuning, R. Eckstein, et al.. (1988). Rh antibodies against the pretransplant red cells following Rh‐incompatible bone marrow transplantation. Transfusion. 28(3). 272–275. 17 indexed citations
14.
Kolb, HJ, et al.. (1986). Clonogenic assays and engraftment in allogeneic bone marrow transplantation.. PubMed. 1(2). 221–6. 4 indexed citations
15.
Clemm, Ch., Reiner Bartl, W. Siegert, Philipp Baumann, & W. Wilmanns. (1986). Missing Y Chromosome in 2 Patients with Chronic Myelocytic Leukemia. Acta Haematologica. 76(1). 57–59. 2 indexed citations
16.
17.
Clemm, Ch., R. Hartenstein, B Mayr, & W. Wilmanns. (1984). Bleomycin-induzierte Lungeninfiltrate bei der Behandlung von Hodenkarzinomen. Journal of Molecular Medicine. 62(3). 138–144. 3 indexed citations
18.
Clemm, Ch., et al.. (1983). [Thrombopenia, hemolytic anemia and neurologic disorders].. PubMed. 24(4). 226–9. 1 indexed citations
19.
Jehn, U., Ch. Clemm, & W. Wilmanns. (1981). Behandlungsergebnisse akuter Leukämien im Erwachsenenalter: Kritische Analyse eines unselektionierten Krankengutes. Oncology Research and Treatment. 4(2). 60–72. 3 indexed citations
20.
Werder, Klaus von, Ch. Clemm, W. Kerner, & Peter Christian Scriba. (1975). A hPRL-RIA using antibodies against the "little" component of serum-hPRL. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. C. W. Marsh Breakdown of academic impact, for papers by Steve Kornblau Breakdown of academic impact, for papers by Marion M. Roberts Breakdown of academic impact, for papers by Monic J. Stuart Breakdown of academic impact, for papers by C Anasetti Breakdown of academic impact, for papers by Jérôme Rey Breakdown of academic impact, for papers by Maria Rosa Motta Breakdown of academic impact, for papers by Édouard Forcade Breakdown of academic impact, for papers by P Coser Breakdown of academic impact, for papers by Stern Ac
Rankless by CCL
2026